Decreased expression of CD90 was reported to be associated with a loss of human MSC immunosuppressive activity [31], thus low CD90 expression observed in CB-MSCs might indicate a loss of immunosuppressive function, thereby granting tumor-targeting T cells to execute tumor killing. The gene discussed is THY1; the disease is neoplasm.